| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | RFI EMERGENTES | 134,281361 | 26/02/2026 | 0,11% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | RFI EMERGENTES | 114,423565 | 26/02/2026 | 0,18% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | BIOTECNOLOGÍA | 124,540000 | 27/02/2026 | 6,05% | 30,35% | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 800,093181 | 27/02/2026 | 5,94% | 25,85% | ** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | BIOTECNOLOGÍA | 360,982634 | 27/02/2026 | 6,11% | 29,77% | ** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | BIOTECNOLOGÍA | 117,780601 | 27/02/2026 | 6,15% | 30,55% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 88,580000 | 27/02/2026 | -0,73% | 6,44% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 72,010000 | 27/02/2026 | -0,54% | 9,75% | *** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | 91,720000 | 27/02/2026 | -0,76% | 4,94% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | RVI CHINA | 80,750000 | 27/02/2026 | -0,93% | 1,29% | * |
